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J Hypertens 33:1276–1283 Copyright  2015 Wolters Kluwer Health, Inc. All rightsObjectives: Extensive endurance training and arterial
hypertension are established risk factors for atrial
fibrillation. We aimed to assess the proportion of masked
hypertension in endurance athletes and the impact on
cardiac remodeling, mechanics, and supraventricular
tachycardias (SVT).
Methods: Male participants of a 10-mile race were
recruited and included if office blood pressure was normal
(<140/90mmHg). Athletes were stratified into a masked
hypertension and normotension group by ambulatory
blood pressure. Primary endpoint was diastolic function,
expressed as peak early diastolic mitral annulus velocity
(E’). Left ventricular global strain, left ventricular mass/
volume ratio, left atrial volume index, signal-averaged P-
wave duration (SAPWD), and SVT during 24-h Holter
monitoring were recorded.
Results: From 108 runners recruited, 87 were included in
the final analysis. Thirty-three (38%) had masked
hypertension. The mean age was 428 years. Groups did
not differ with respect to age, body composition,
cumulative training hours, and 10-mile race time. Athletes
with masked hypertension had a lower E’ and a higher left
ventricular mass/volume ratio. Left ventricular global strain,
left atrial volume index, SAPWD, and SVT showed no
significant differences between the groups. In multiple
linear regression analysis, masked hypertension was
independently associated with E’ (beta¼—0.270,
P¼0.004) and left ventricular mass/volume ratio
(beta¼0.206, P¼0.049). Cumulative training hours was
the only independent predictor for left atrial volume index
(beta¼0.474, P<0.001) and SAPWD (beta¼0.481,
P<0.001).
Conclusion: In our study, a relevant proportion of middle-
aged athletes had masked hypertension, associated with a
lower diastolic function and a higher left ventricular mass/
volume ratio, but unrelated to left ventricular systolic
function, atrial remodeling, or SVT.
Keywords: ambulatory blood pressure, atrial arrhythmias,
diastolic function, left atrial volume index, left ventricular
mass/volume ratio
Abbreviations: A’, peak late diastolic mitral annulus
velocity; BP, blood pressure; E’, peak early diastolic mitral
annulus velocity; PAC, premature atrial contraction;
SAPWD, signal-averaged P-wave duration Copyright © 2015 Wolters Kluwe
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ompared to the general population, middle-aged
endurance athletes have an approximately five-fold
increased risk of developing atrial fibrillation [1].
Atrial remodeling due to repetitive episodes of volume
overload, atrial stretching and inflammation, an elevated
vagal tone, and premature atrial contractions are suggested
contributing factors [2], recently confirmed in an animal
model of exercising rats [3]. Arterial hypertension is the
most prevalent risk factor in athletes [4], and a potent risk
factor for atrial fibrillation [5]. In collegiate American-style
football players, a postseasonal increase in blood pressure
(BP) has been reported. Forty-seven percent of athletes met
criteria for prehypertension and 14% for stage 1 hyper-
tension. In linemen, the increase in BP was associated with
an increase in left ventricular mass and concentric left
ventricular remodeling [6]. For a comparable amount of
training and performance, male endurance athletes had a
significantly higher BP compared to their female counter-
parts. The higher BP in male athletes was associated with
concentric left ventricular remodeling, an altered diastolic
function, a more pronounced left atrial remodeling, and a
higher proportion of paroxysmal atrial fibrillation [7]. The
higher BP in male athletes may, at least in part, explain the
striking male predominance of atrial fibrillation in athletes
[1]. Masked hypertension is defined as a normal office BP in
the presence of an elevated BP during the 24-h BPmeasure-
ment [8]. It receives increasing attention since it has been
assigned a nearly similar risk of cardiovascular morbidity as
sustained hypertension [8,9]. In the general population, the
prevalence lies in the range of 8–20%, but can be up to 50%
in the treated hypertensive patients [8]. The prevalence of
masked hypertension in athletes is unknown. The aim of
our study was to assess the proportion of masked hyper-
tension in male endurance athletes and the impact onr Health, Inc. All rights reserved.
reserved.
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Masked hypertension in endurance athletescardiac morphology, mechanics, and supraventricular
tachycardias (SVT). We hypothesized that masked hyper-
tension would be an independent predictor of a reduced
diastolic function and increased cardiac remodeling, thus
acting as a risk factor for atrial fibrillation [10,11].
METHODS
Participants and protocol
The Grand Prix of Bern is one of the most popular 10-mile
races in Switzerland with over 25 000 participants. Male
runners, aged 30 years and older, were recruited for a study
on cardiac remodeling by an open letter of invitation
published on the homepage of the 2011th events [12,13].
The term ‘hypertension’ was not mentioned in the invitation
letter to minimize selection bias. All athletes applied via
electronic mail. Athletes were classified based on their
experience in endurance competitions in three categories:
leisure-time runners (no or up to one previous marathon
participation), marathon runners (more than one marathon
participation), and ultraendurance athletes (participation in
78 or 100-km races or long-distance triathlons). An equal
number of athletes were randomly selected from each
category. Analyses were performed from July 2011 to June
2012, at least 4 weeks after a competition. All athletes
provided written informed consent and the protocol was
approved by the local ethics committee.
We excluded athletes with a history of cardiovascular
disease, medication intake, ergogenic aids usage, or an
office BP at least 140/90mmHg at the initial visit. Office
BP was defined as optimal (<120/80mmHg), normal
(120/80–129/84mmHg), and high-normal (130/85–139/
89mmHg) [9]. The 24-h ambulatory BP monitoring was
performed. Also, 24-h, daytime, and night-time SBP and
DBPwere recorded. Masked hypertension was diagnosed if
24-h and/or daytime BP were above the established cut-off
values (mean SBP 130 and/or mean DBP 80mmHg,
daytime SBP 135 and/or daytime DBP 85mmHg) [9].
The athletes were then stratified into a normotension and a
masked hypertension group.
Assessment included transthoracic echocardiography
with Doppler tissue imaging and two-dimensional speckle
tracking, signal-averaged analysis of the ECG, and 24-h
ambulatory Holter monitoring. Before the tests, the athletes
were asked to abstain from food, and caffeine-containing
substances (3 h) and alcohol ( 24 h), and they were told
to refrain from vigorous exercise training for 24 h before the
tests. All measurements were performed on the same day,
starting with office BP measurement, followed by signal-
averaged ECG, transthoracic echocardiography, and pre-
paration for 24-h BP and Holter monitoring. In case of an
ambulatory BPmonitoringwith insufficient data quality, the
measurement was repeated within 1 week.
Primary endpoint was diastolic function, expressed as
peak early diastolic mitral annulus velocity (E’). Secondary
endpoints included parameters of left ventricular systolic
function (left ventricular global strain), left ventricular
remodeling (left ventricular mass/volume ratio), left atrial
remodeling [left atrial volume index and signal-averaged P-
wave duration (SAPWD)], premature atrial contractions
(PACs), and SVT during 24-h Holter monitoring. Copyright © 2015 Wolters Kluwer
Journal of HypertensionOffice blood pressure
Resting BP was measured three times in the right arm with
an oscillometric device (Dinamap XL; Criticon Inc., Tampa,
Florida, USA) after a 10-min rest in supine position. The cuff
size was adjusted to the arm’s circumference. The first
measurement was discarded and the mean of the two last
measurements was used for data analysis.
Sports history
A comprehensive questionnaire was used to assess personal
and sports histories. Lifetime training hours were based on
the athletes’ training diaries and/or estimations, and were
calculated as follows: average endurance and strength train-
ing hours per week multiplied by 52 weeks multiplied by
training years after the age of 18 [12,14]. Furthermore, cumu-
lative lifetime competitions were assessed and expressed as
marathonequivalents: 10kmrace 0.24, 10mile race 0.38,
half marathon 0.5, marathon 1.0, mountain marathon
 1.3, 78km race 1.8, ironman triathlon race 2.5, and
100km race 2.5.
Ambulatory blood pressure
A 24-h BP measurement was performed using a certified
oscillometric device (Ultralite 90217; Spacelabs Healthcare)
and following the guidelines of the European Society of
Hypertension [9]. Daytime and night-time hours were
defined based on the athletes’ diary. Four daytime and
two night-time measures per hour were performed. A valid
recording was defined as at least 90% of correct measure-
ments. Invalid recordings were repeated, if possible. Mean
24-h, daytime, and night-time values of the SBP and DBP
were extracted using the ABP Report Management System
(Spacelabs Healthcare).
Transthoracic echocardiography
Standard transthoracic echocardiography was performed
on a Phillips iE33 System (X5-1 transducer; Phillips Medical
Systems, Zurich, Switzerland). Left ventricular diastolic
function was evaluated using standard parameters. Peak
early and late diastolic velocities at the septal and lateral
side of the mitral annulus were recorded, and the mean
value was calculated and defined as E’ mean and A’ mean
[15]. Diastolic dysfunction was defined as E’ septal less than
8 cm/s and/or E’ lateral less than 10 cm/s [15]. Maximal left
atrial volumewas calculated using the biplane summed disc
method [16]. A markedly enlarged left atriumwas defined as
left atrial volume index at least 34ml/m2 [16]. Left ventric-
ular dimensions and wall thickness were measured using
M-mode, and the left ventricular mass and relative wall
thickness were calculated. Left ventricular volumes were
obtained using the biplane summed discs method, and the
left ventricular mass/volume ratio and ejection fraction
were derived [16,17]. Mass and volume parameters were
indexed for the body surface area. Strain analysis of the left
ventricle (LV) was performed by two-dimensional speckle-
tracking echocardiography in apical four, two, and three-
chamber views [18]. High frame loops (70–80Hz) were
acquired during breath hold for five cardiac cycles andwere
analyzed off-line using the QLAB CMQ software (Philips
Medical Systems, Zurich, Switzerland). All measurements Health, Inc. All rights reserved.
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points in the endocardium, the software automatically
traces the endocardium and epicardium of the left ventric-
ular wall for each view and divides the septum and LV-free
wall into basal, middle, and apical segments. The peak
negative systolic strain was calculated from the six segments
of each view, in inferoseptal and anterolateral walls (four-
chamber view), inferior and anterior walls (two chamber
view), and inferolateral and anteroseptal walls (three-
chamber view). The left ventricular global strain was deter-
mined by averaging all values of the 18 segments of the
three views. For intraobserver variability, a comparison
of the left ventricular global strain was performed in 25
athletes, as described previously [13].
Twenty-four-hour Holter monitoring
A three-channel ECG was recorded with a Lifecard CF
digital recorder (Spacelabs Healthcare) and manually
analysed and interpreted using the Pathfinder Software
(Spacelabs Healthcare). PAC and SVT (three or more con-
secutive PACs) were classified according to onset and QRS
morphology. Spectral power analysis of heart rate varia-
bility was performed and the high-frequency/low-
frequency power ratio was used as a surrogate of the
sympatho-vagal balance [19].
Signal-averaged ECG and analysis of P wave
A 12-lead ECG was recorded at a paper speed of 25mm/s
with the athlete in the supine position (MAC5500; GE
Healthcare, Glattbrugg, Switzerland). The method for
recording and analyzing a signal-averaged ECG P-wave
has been described previously [7].
Data analysis
The data were analyzed with SPSS Software for Windows
(Version 17.0, SPSS Inc., Chicago, Illinois, USA). The nor-
mality of the quantitative variables was verified with the
Shapiro–Wilk test. Normally distributed data were pre-
sented as mean SD, and variables with skewed distri-
bution were shown as median (minimum, maximum).
Continuous variables were compared with the Student’s t
test or Mann–Whitney U test, as appropriate. A chi-square
test was used to compare the categorical data. Multiple
linear regression analyses were performed to determine
predictor for primary and secondary endpoints. Independ-
ent variables were masked hypertension, cumulative train-
ing hours, and age. Dependent variables were parameters
of diastolic function (E’ mean), left ventricular remodeling
(left ventricular volume/mass ratio), and left atrial remod-
eling (left atrial volume index and SAPWD). P value of less
than 0.05 was considered to indicate statistical significance.
Relative risk and 95% confidence intervals (CIs) for having
masked hypertension was calculated for athletes with
optimal vs. nonoptimal office BP.
Sample size calculation (G-Power Version 3.1.9.2, Uni-
versity of Du¨sseldorf, Germany) for the primary endpoint
(E’) was based on a previous study in male, middle-aged
amateur athletes with a mean E’ of 12.9 1.7 cm/s [14]. We
assumed a 10% lower E’ (11.6 1.5 cm/s) in the masked
hypertension group to be clinically meaningful (effect size
0.81). With an alpha of 0.05 (one-sided) and a power of Copyright © 2015 Wolters Kluwe
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per group. Assuming a prevalence of masked hypertension
in our population of 20% [8], 100 athletes had to be
included. Assuming that 90% of recruited athletes would
meet inclusion criteria and have sufficient data quality, we
aimed to include approximately 110 athletes.
RESULTS
Participants’ characteristics
A total of 208 runners applied for participation and were
classified according to the predefined three categories.
Athletes of each category were ordered according to
electronic mail entry date. On the basis of the sample size
calculation, 36 athletes had to be selected from each
category. The total number of applicants per category
was divided by 36, and accordingly every second or third
athlete was selected. Twelve athletes had to be excluded
because of systemic arterial hypertension, and one because
of treated hypercholesterolemia. Eight athletes had insuffi-
cient 24-h BP measurements; thus 87 were included in the
final analysis. Thirty-three athletes (38%) showed elevated
24-h and/or daytime BP measurements and were allocated
to the masked hypertension group.
Mean age was 42 8 years, with no significant differ-
ences between groups. Additionally to ambulatory BP,
office BP was significantly higher in the masked hyper-
tension group, compared to the normotension group
(Table 1). The relative risk of having masked hypertension
with a nonoptimal office BP was 2.03 (95% CI 1.39–2.96).
The spectrum of recruited athletes reached from leisure-
time runners with no experience in competitions to semi-
professional ultraendurance athletes with a maximum of 23
endurance training hours per week, and 82 marathon
equivalents of competitions. Mean exercise training years,
median endurance and strength training hours, the athletic
category, and participation in competitions were balanced
between the groups, and there were no differences with
regard to parameters of body composition and race per-
formance (Table 1).
Left ventricular mechanics and morphology
In athletes with masked hypertension, E’mean and the E’/A’
ratio were significantly lower, and the E/E’ ratio and left
ventricular mass/volume ratio were significantly higher,
compared to normotensive athletes. Left ventricular mass
index showed a tendency towards higher values. Left
ventricular global strain and other parameters of left ven-
tricular function and morphology showed no group differ-
ences (Fig. 1 and Table 2). Intraclass correlation coefficient
for left ventricular global strain was 0.867, which is a very
good agreement. The proportion of athletes with diastolic
dysfunction was not different between the normotension
and the masked hypertension group (9.3 vs. 12.1%;
P¼ 0.466). There was a significant correlation of the left
ventricular mass/volume ratio with E’mean in an univariate
model (R¼ 0.265, P¼ 0.013). However, the association was
lost when age was entered as an independent variable. Age
and masked hypertension were independent predictors of
E’mean and the left ventricular mass/volume ratio in multi-
variate models (Fig. 2, Table 3).r Health, Inc. All rights reserved.
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TABLE 1. Baseline characteristics of endurance athletes, stratified according to 24-h ambulatory blood pressure measurement
Variable Normotension (n¼54) Masked hypertension (n¼33) P value
Age (years) 428 428 0.794
BMI (kg/m2) 22.91.8 23.41.8 0.240
Body surface area (m2) 1.90.1 1.90.1 0.256
Office SBP (mmHg) 119.18.4 127.26.9 <0.001
Office DBP (mmHg) 77.25.5 83.14.9 <0.001
Office BP <120/80mmHg (n) 30 (55.6%) 7 (21.2%) 0.003
Office BP 120/80 to 129/84mmHg (n) 18 (33.3%) 11 (33.3%)
Office BP 130/85 to 139/89mmHg (n) 6 (11.1%) 15 (45.5%)
24-h SBP (mmHg) 119.55.4 130.17.3 <0.001
24-h DBP (mmHg) 76.53.4 84.23.6 <0.001
Daytime SBP (mmHg) 121.85.7 133.27.6 <0.001
Daytime DBP (mmHg) 78.53.5 86.93.7 <0.001
Night-time SBP (mmHg) 105.36.2 113.16.8 <0.001
Night-time DBP (mmHg) 63.74.8 69.84.8 <0.001
Training volume
Exercise training (years) 14.510.2 12.86.8 0.343
Endurance training (hours :min/week)a 4 : 00 (1 : 00, 23 : 00) 4 : 30 (0 : 30, 13 : 00) 0.719
Strength training (hours :min/week)a 0 : 37 (0 : 00, 3 : 00) 0 : 30 (0 : 00, 3 : 00) 0.399
Cumulative lifetime training (h)b 2171 (0, 14872) 2340 (0, 16640) 0.431
Athletic category and participation in competitions
Leisure time runners (n) 21 (38.9%) 14 (42.4%) 0.498
Marathon runners (n) 21 (38.9%) 9 (27.3%)
Ultraendurance athletes (n) 12 (22.2%) 10 (30.3%)
Marathon equivalents (n)c 2.0 (0, 82) 2.0 (0, 65) 0.510
Performance
10-mile race time (hours :min) 1 : 100 : 10 1 : 090 : 09 0.933
Data are expressed as mean SD, median (minimum, maximum) or %. BP, blood pressure.
aEstimated averages of the past 3 months.
bAverage total endurance and strength training hours per week52 training years.
c10-km races0.24, 10-mile race 0.38, half marathon0.5, flat marathon1.0, mountain marathon1.3, 78-km race1.8, Ironman triathlon race2.5, and 100-km race2.5.
Masked hypertension in endurance athletesLeft atrial remodeling and supraventricular
tachycardias
The left atrial volume index and parameters of signal-
averaged P-wave analysis showed no significant differences
between the groups (Fig. 1 and Table 4). The proportion of
athletes with a markedly enlarged left atrium (>34ml/m2)
was not statistically significantly different between the
normotension and the masked hypertension group (40.7
vs. 30.3%, respectively; P¼ 0.327). Cumulative training
hours was the only independent predictor of the left atrial
volume index and the SAPWD in the multivariate models
(Table 3). PACs occurred significantly more frequently
in the normotension group and were inversely correlated
with the low-frequency/high-frequency power ratio
(R¼—0.297, P¼ 0.005). The burden of SVT was low and
showed no significant differences between the groups
(Table 4).
DISCUSSION
In our sample of middle-aged endurance athletes, the
proportion of athletes with masked hypertension was sub-
stantially higher (38%) than estimates from the general
population (8–20%) [8], but comparable to male pro-
fessional football players [20]. Importantly, the prevalence
of masked hypertension depends on the definition.
Asayama et al. [21] demonstrated in a middle-aged
untreated population an increase of the prevalence from
9.7 to 15.0% and 19% if 24-h BP, 24-h or daytime BP, or 24-h,
daytime or night-time BP, respectively, had been used. In
our study, we used the criterion of 24-h or daytime BP. Copyright © 2015 Wolters Kluwer
Journal of HypertensionInclusion of night-time BP would have increased the preva-
lence to 40% without a significant impact on the primary
endpoint E’.
Interestingly, in the study by Asayama et al., the masked
hypertension group had a higher daytime SBP, compared to
our athletic population (139.1 10.0 vs. 133.2 7.6mmHg),
whereas the daytime DBP was lower (84.9 7.6 vs.
86.9 3.7mmHg) in their population. This may be due to
the fact that 24 out of our 33 athletes (73%) qualified for the
masked hypertension group using the DBP criterion. Partici-
pants in the study by Asayama et al.were slightly older, and
more obese, and it can be speculated that the pathophysi-
ology of masked hypertension may be different from a
normal-weight athletic population.
Although exercise training in general may prevent hy-
pertension by positively affecting endothelial function and
arterial stiffness [22,23], repetitive episodes of high-intensity
strength or endurance exercise may contribute to a rise in
BP, possibly by an increased sympathetic activity [6,20].
However, our study was not intended to demonstrate a
causal relationship between endurance sports practice and
masked hypertension. Masked hypertension was associ-
ated with a lower diastolic function and a higher left
ventricular mass/volume ratio, indicating a more pro-
nounced structural remodeling of the LV, consistent with
a study in American-style football players [6]. However, the
percentage of diastolic dysfunction was low and equally
distributed between the groups, and only two athletes (one
in the normotension and one in the masked hypertension
group) presented with an E/E’ ratio of at least 9, suggestive
of an elevated left atrial pressure [15]. Health, Inc. All rights reserved.
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–10.0
–12.5
–17.5
–20.0
–22.5
–25.0
–15.0
40.0
35.0
30.0
25.0
20.0
15.0
10.0
Normotension Masked
hypertension
Normotension Masked
hypertension
Normotension Masked
hypertension
Normotension Masked
hypertension
2.00
1.75
1.50
1.25
1.00
14.0
12.0
10.0
8.0
6.0
4.0
LV
 m
as
s/
vo
lu
m
e 
ra
ti
o
 (
g
/m
l)
L
A
 v
ol
um
e 
in
de
x 
(m
l/
m
2 )
E
’ m
ea
n
 (
cm
/s
)
LV
 g
lo
ba
l s
tr
ai
n
 (
%
)
P = 0.006
P = 0.935
P = 0.618P = 0.043
FIGURE 1 Characteristics of the normotension and the masked hypertension group with regard to parameters of LV diastolic function (E’ mean), systolic function (LV
global strain), LV remodeling (LV mass/volume ratio), and LA remodeling (LA volume index). Columns represent means and bars represent 2 standard errors. LA, left atrial;
LV, left ventricular.
TABLE 2. Echocardiography
Variable Normotension (n¼54) Masked hypertension (n¼33) P value
Mean heart rate during examination (b.p.m.) 537 537 0.878
LVEDVI (ml/m2) 6210 599 0.210
LVESVI (ml/m2) 214 214 0.542
LV ejection fraction (%) 665 655 0.625
LVMI (g/m2) 10018 10419 0.258
Relative wall thickness 0.38 0.06 0.380.06 0.897
Peak E (cm/s) 70.010.5 71.013.2 0.694
Peak A (cm/s) 43.910.2 47.59.9 0.120
E/A ratio 1.660.44 1.540.38 0.197
DT (ms) 17931 18231 0.654
IVRT (ms) 7911 826 0.329
A’ mean (cm/s) 9.42.0 10.64.7 0.114
E’/A’ ratio 1.380.36 1.160.34 0.008
E/E’ ratio 6.01.3 6.61.2 0.046
Data are expressed as mean SD. A’ mean, peak late diastolic septal and lateral mitral annulus velocity; DT, deceleration time; E/E’, peak early mitral inflow velocity to peak early
diastolic mitral annulus velocity ratio; IVRT, isovolumic relaxation time; LVEDVI, left ventricular end diastolic volume index; LVESVI, left ventricular end systolic volume index; LVMI, left
ventricular mass index.
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Masked hypertension in endurance athletesLeft ventricular global strain as a marker of left ventric-
ular systolic function showed no significant group differ-
ences. Values were comparable with data from a study
including healthy and normotensive power-endurance ath-
letes [24]. For patients with high-normal BP or hyperten-
sion, both significantly lower values for left ventricular
global strain [24,25] and values comparable to normoten-
sive patients [26] have been published. Probably, the time
course of BP elevation plays an important role for the
impact on left ventricular mechanics. Athletes in our study
were younger compared to patients with high-normal
BP and reduced left ventricular global strain (42 8 vs.
47 7 years, respectively) [25]. An elevated BP may induce
a deterioration of diastolic function that precedes the
reduction of systolic function.
Consistent with the relatively low E/E’ ratio in the
masked hypertension, we found no association of masked
hypertension with parameters of left atrial remodeling.
Despite the fact that the left atrium was markedly dilated
in 32 athletes (36.8%), this was only attributable to the
cumulative lifetime training hours. Also the SAPWD, a
surrogate marker for atrial fibrosis, was only associated
with cumulative lifetime training hours. Interestingly, the
SAPWDwas substantially longer in our cohort compared to
reference values from an age-matched nonathletic popu-
lation (140 13 vs. 117 12ms, respectively) [27]. Values
above 130ms have been associated with a higher risk of Copyright © 2015 Wolters Kluwer
TABLE 3. Independent predictors for parameters reflective of cardiac
Beta coefficient Stan
E’ mean (R2¼0.293)
Age 0.108
Masked hypertension 1.122
LV mass/volume ratio (R2¼0.119)
Age 0.010
Masked hypertension 0.137
LA volume index (R2¼0.241)
Cumulative training hours 0.001
SAPWD (R2¼0.288)
Cumulative training hours 0.002
Multiple linear regression analysis including masked hypertension (0¼no, 1¼ yes), cumulative t
diastolic septal and lateral mitral annulus velocity; LA, left atrial; LV, left ventricular; SAPWD, sig
Journal of Hypertensionatrial fibrillation [28]. Nevertheless, the burden of SVT
during 24-h Holter monitoring was low in our study and
equally distributed between the groups. Interestingly, PACs
occurred more frequently in the normotension groups
and showed an inverse correlation with markers of the
sympatho-vagal balance, suggesting an association with
vagal activity.
Taken together, atrial remodeling in our cohort of endur-
ance athletes was related solely to cumulative training
hours, which is consistent with other studies [14,29]. One
could speculate that repetitive episodes of volume overload
during training and competition, associated with atrial
stretching, elevated atrial wall tension, and parameters of
inflammation [30], would contribute substantially more to
structural remodeling of the left atrium than a mildly altered
diastolic function, especially when the left atrial pressure is
not substantially elevated.
In contrast to a recently published meta-analysis of
athletes with atrial fibrillation, our participants were much
younger (51 9 vs. 42 8 years, respectively) [1]. Diastolic
function declines with age [15], consistent with the strong
inverse association of E’ mean with age in our cohort.
Although it has been suggested that the age-related decline
of ventricular compliance may be mitigated by endurance
training [31], an elevated BP could abolish this positive
effect or even aggravate the age-related decline. On the
long term, uncontrolled masked hypertension in athletes
could promote diastolic dysfunction with elevated left atrial
pressures like demonstrated in a nonathletic population
[32], and contribute to atrial remodeling and atrial fibrilla-
tion later in life.
Limitations
We included male endurance runners and triathletes; thus,
our findings cannot be generalized to athletes of other types
of sports or female athletes. We cannot exclude that unre-
ported analgesic use or alcohol consumption may have
contributed to masked hypertension [33]. We did not per-
form a laboratory test to rule out kidney dysfunction. Office
BP was measured only in the right arm, so a possibly higher
BP in the left arm was not taken into account. Due to our
rather small sample size, the results should be confirmed in
a larger population. The determination of the left ventric-
ular mass/volume ratio may be imprecise using two-dimen-
sional echocardiography. Three-dimensional techniques
have a better reproducibility [34], but were not available Health, Inc. All rights reserved.
remodeling
dard error beta Standardized b P value
0.024 0.425 <0.001
0.384 0.270 0.004
0.004 0.250 0.018
0.069 0.206 0.049
0.000 0.474 <0.001
0.000 0.481 <0.001
raining hours, and age. Only significant associations are displayed. E’ mean, peak early
nal-averaged P-wave duration.
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TABLE 4. Signal-averaged ECG and 24-h Holter monitoring
Variable Normotension (n¼54) Masked hypertension (n¼33) P value
Signal-averaged ECG
SAPWD (ms) 14114 1389 0.259
Integral P wave (mVs) 882310 786223 0.604
RMS 20 (mV) 4.32.1 4.62.2 0.136
24-h Holter monitoring
Premature atrial contractions (n) 92 (0, 1870) 9 (0, 99) 0.023
SV arrhythmias (n) 0 (0, 4) 0 (0, 4) 0.112
Premature ventricular contractions (n) 14 (0, 173) 8 (0, 75) 0.486
Mean HR (b.p.m.) 64 (46, 86) 65 (49, 78) 0.462
Minimal HR (b.p.m.) 44 (31, 58) 45 (33, 57) 0.536
Maximum HR (b.p.m.) 127 (83, 184) 128 (83, 177) 0.746
Data are expressed as mean SD or median (minimum, maximum). b.p.m., Beats per minute; HR, heart rate; RMS 20, root mean squares voltage in terminal 20ms of the P wave;
SAPWD, signal-averaged P-wave duration; SV, supraventricular.
Trachsel et al.at the time of the study measurements. The low arrhythmic
burden and absence of sustained SVT could be due to the
low-risk participants included in the study. Further, non-
detection of SVT may have been related to the short
monitoring period of only 24 h. Seven days of Holter
monitoring would have been more appropriate to rule
out paroxysmal atrial fibrillation [35], but was impractical
for athletes in preparation of competitions. The study was
not powered to detect differences in arrhythmic burden
between the groups.
Perspectives
In our study, a relevant proportion of middle-aged endur-
ance athletes had masked hypertension, associated with a
lower diastolic function and a higher left ventricular mass/
volume ratio, but unrelated to left ventricular systolic func-
tion, atrial remodeling, or SVT. However, uncontrolled
masked hypertension has a potential to contribute to atrial
remodeling and atrial fibrillation in the long term.
While most endurance athletes at risk for atrial fibrilla-
tion would feel reluctant to reduce their training volume to
prevent atrial remodeling, arterial hypertension is an easily
modifiable risk factor. Current guidelines recommend
office BP measurements for middle-aged athletes, engaged
in high-intensity activities [36]. Our data suggest that the
relative risk of having masked hypertension is two-fold
increased in the presence of a nonoptimal office BP
(120/80mmHg), which is consistent with studies includ-
ing nonathletes [37]. Ambulatory BP measurements may be
indicated is these athletes to rule out uncontrolled
masked hypertension.
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Reviewer 1
The paper ‘Masked hypertension and cardiac remodeling in
middle-aged endurance athletes’ was aimed at investigating
the frequency of masked hypertension in middle-aged
endurance athletes and its impact on cardiac remodeling,
mechanics and supraventricular tachycardia (SVT). This is
an interesting study with relevant and novel findings sup-
porting the idea that on long-term, masked hypertension
could promote diastolic dysfunction with elevated left atrial
pressures and contribute to atrial remodeling and atrial
fibrillation later in the life of athletes. Although supported
by a proper statistical analysis, the results of this study,
coming from a small sample, need to be confirmed by a
study performed in a larger population of all types’ athletes.Reviewer 2
In this manuscript the Authors aimed to assess the pro-
portion of masked hypertension in middle-aged endurance
male athletes, and impact of this dysfunction on cardiovas-
cular remodeling. Masked hypertension is an important
parameter, associated with a lower diastolic function and
a higher left ventricular mass. Uncontrolled masked hyper-
tension could promote atrial remodeling and atrial fibrilla-
tion in athletes later in their life. Due to the nature of the
present study, it is unclear if the occurrence of masked
hypertension higher in endurance athletes vs. general
population, and how the main finding of the study applies
to female athletes. Health, Inc. All rights reserved.
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